However, in our studies of MZF1 post-translational modification and their effect on protein stability, we found that in ErbB2-expressing breast cancer cells, MZF1 is a very stable protein and its stability was not affected by mutating its SUMO sites (Brix and Kallunki, unpublished observations). The gene discussed is ERBB2; the disease is breast carcinoma.